Management of Preeclampsia
The definitive treatment for preeclampsia is delivery of the fetus and placenta, with timing based on gestational age, maternal condition, and fetal status. 1, 2
Diagnosis and Risk Assessment
- Preeclampsia is diagnosed by hypertension (BP ≥140/90 mmHg) after 20 weeks gestation with proteinuria (≥30 mg/mmol or 0.3 mg/mg protein/creatinine ratio) 1
- Risk factors include:
- History of preeclampsia
- Previous adverse pregnancy outcomes
- Maternal comorbidities
- Multifetal gestation
- Nulliparity
- Obesity
- African American race
- Advanced maternal age 1
Management Algorithm
Mild Preeclampsia (≥37 weeks)
- Proceed with delivery (similar outcomes to normotensive pregnancy) 2
Mild Preeclampsia (<37 weeks)
- Close maternal and fetal monitoring
- Blood pressure control with first-line oral agents
- Delivery at 37 weeks or earlier if condition worsens 1
Severe Preeclampsia (≥34 weeks)
Severe Preeclampsia (<34 weeks)
- Administer corticosteroids for fetal lung maturation 1
- Magnesium sulfate for seizure prophylaxis 1, 3
- Antihypertensive therapy for blood pressure control 1
- Consider expectant management for 24-48 hours to allow corticosteroids to take effect 2
- Immediate delivery if:
Pharmacological Management
Seizure Prophylaxis
- Magnesium sulfate is the drug of choice 1, 3
- Initial dose: 4-5g IV over 15-20 minutes
- Maintenance: 1-2g/hour continuous IV infusion
- Continue for 24 hours postpartum
- Target serum level: 6 mg/100 mL 3
- Maximum daily dose: 30-40g/24 hours 3
- Monitor for toxicity: loss of deep tendon reflexes, respiratory depression, heart block 3
Antihypertensive Therapy
Severe Hypertension (BP ≥160/110 mmHg)
- First-line IV medications:
- Target BP: 140-150/90-100 mmHg 1
Chronic Hypertension Management
- First-line oral agents:
- Methyldopa
- Labetalol 1
- Target diastolic BP: 85 mmHg (systolic 110-140 mmHg) 1
- ACE inhibitors are contraindicated during pregnancy 1, 5
Laboratory Monitoring
- Complete blood count with platelets
- Liver function tests
- Renal function
- Uric acid
- Fibrinogen levels (to evaluate for DIC) 1
Fetal Monitoring
- Continuous fetal heart rate monitoring in patients with preeclampsia
- Ultrasound for fetal growth assessment
- Amniotic fluid volume assessment
- Doppler studies if growth restriction is suspected 1
Prevention Strategies
- Low-dose aspirin (81 mg/day) between 12-16 weeks of gestation for high-risk women 1
- Calcium supplementation (1.0-1.5g daily) for women with low calcium intake 1
- Healthy diet focusing on fruits, vegetables, and whole grains 1
Postpartum Care
- Continue blood pressure monitoring every 4-6 hours for at least 3 days
- Taper antihypertensive medications slowly after days 3-6
- Follow-up within 1 week if still on antihypertensives at discharge 1
- Home blood pressure monitoring with proper technique and appropriate cuff size 1
Important Caveats
- Magnesium sulfate should not be used beyond 5-7 days in pregnancy as it can cause fetal abnormalities 3
- Diuretics are controversial and generally not recommended as first-line therapy as they reduce plasma volume expansion 5
- Calcium antagonism can partially reverse magnesium toxicity 3
- Women with history of preeclampsia have increased risk of cardiovascular disease later in life and require long-term follow-up 6